Maslo C, Girard P M, Urban T, Guessant S, Rozenbaum W
Service des Maladies Infectieuses et Tropicales, Hôpital Rothschild, Paris, France.
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1263-4. doi: 10.1164/ajrccm.156.4.97-02028.
We report the effectiveness of ribavirin in an AIDS patient with multinodular pneumonia due to adenovirus. A 38-year-old AIDS patient who experienced multiple opportunistic infections and whose CD4 lymphocyte count was 5/mm3 developed bilateral nodular lung opacities. Lung surgical biopsy yielded necrotizing pneumonitis with characteristic nuclear inclusions and positive immunocytology with adenovirus antibodies. Marked clinical and radiological improvement was obtained after intravenous then oral ribavirin. Ribavirin was discontinued after 40 d because of anemia. Relapse of pneumonia with respiratory distress led to death 8 mo later. This observation illustrates a rarely reported pulmonary opportunistic infection in AIDS and the potential value of ribavirin therapy for adenovirus pneumonia.
我们报告了利巴韦林对一名因腺病毒感染导致多结节性肺炎的艾滋病患者的疗效。一名38岁的艾滋病患者,经历了多次机会性感染,其CD4淋巴细胞计数为5/mm³,出现双侧肺部结节状混浊。肺手术活检显示为坏死性肺炎,伴有特征性核内包涵体,腺病毒抗体免疫细胞学检查呈阳性。静脉注射后口服利巴韦林后,临床和影像学均有明显改善。40天后因贫血停用利巴韦林。8个月后,肺炎复发并伴有呼吸窘迫,导致患者死亡。本观察结果说明了艾滋病中一种罕见报道的肺部机会性感染,以及利巴韦林治疗腺病毒肺炎的潜在价值。